Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Cardinal Health Inc. recalls RECOMBINATE

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
Products
  • RECOMBINATE
Where it was sold

Nationwide Within the U.S.

Nationwide

Units affected
3 units
About this recall
RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01